Experimental Alzheimer’s drug showing promise

(NBC News) The Alzheimer’s community is buzzing about an experimental drug which is showing great promise in early research.

Doctors say the drug, called Aducanumab, may benefit millions in the earliest stages of the disease.

The drug works to seek and destroy a protein called amyloid that builds up in the brains of Alzheimer’s patients.

It’s a little like bad cholesterol that builds up in arteries, leading to heart disease.

In the small study from drug maker Biogen, the drug reduced amyloid build-up.

It also slowed memory loss in people just starting to show symptoms.

Side effects included headaches, and some had a form of brain swelling at higher doses of the drug.

Experts in the Alzheimer’s field are optimistic about the findings, but urge caution.

Biogen will move its drug to much larger phase three clinical trials: the final stage before submitting data to the food and drug administration.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s